Wearable Biosensors in Congenital Heart Disease: Needs to Advance the Field

Animesh Tandon; Hoang H. Nguyen; Sravani Avula; Dhruv R. Seshadri; Akash Patel; Munes Fares; Orkun Baloglu; Shahnawaz Amdani; Roozbeh Jafari; Omer T. Inan; Colin K. Drummond

doi:10.1016/j.jacadv.2023.100267

Wearable Biosensors in Congenital Heart Disease: Needs to Advance the Field

Animesh Tandon, Hoang H. Nguyen, Sravani Avula, Dhruv R. Seshadri, Akash Patel, Munes Fares, Orkun Baloglu, Shahnawaz Amdani, Roozbeh Jafari, Omer T. Inan, Colin K. Drummond

Research output: Contribution to journal › Review article › peer-review

9 Scopus citations

Abstract

Traditional measures of clinical status and physiology have generally been based in health care settings, episodic, short in duration, and performed at rest. Wearable biosensors provide an opportunity to obtain continuous non-invasive physiologic data from patients with congenital heart disease (CHD) in the real-world setting, over longer durations, and across varying levels of activity. However, there are significant technical limitations to the use of wearable biosensors in CHD. Here, we review current applications of wearable biosensors in CHD; how clinical and research uses of wearable biosensors must consider various CHD physiologies; the technical challenges in developing wearable biosensors for CHD; and special considerations for digital biomarkers in CHD.

Original language	English (US)
Article number	100267
Journal	JACC: Advances
Volume	2
Issue number	2
DOIs	https://doi.org/10.1016/j.jacadv.2023.100267
State	Published - Mar 2023

Keywords

artificial intelligence
congenital heart disease
wearable biosensors
wearables

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine
Dentistry (miscellaneous)

Access to Document

10.1016/j.jacadv.2023.100267

Cite this

@article{71a0755aa84944fba062bfb58e3152e6,

title = "Wearable Biosensors in Congenital Heart Disease: Needs to Advance the Field",

abstract = "Traditional measures of clinical status and physiology have generally been based in health care settings, episodic, short in duration, and performed at rest. Wearable biosensors provide an opportunity to obtain continuous non-invasive physiologic data from patients with congenital heart disease (CHD) in the real-world setting, over longer durations, and across varying levels of activity. However, there are significant technical limitations to the use of wearable biosensors in CHD. Here, we review current applications of wearable biosensors in CHD; how clinical and research uses of wearable biosensors must consider various CHD physiologies; the technical challenges in developing wearable biosensors for CHD; and special considerations for digital biomarkers in CHD.",

keywords = "artificial intelligence, congenital heart disease, wearable biosensors, wearables",

author = "Animesh Tandon and Nguyen, {Hoang H.} and Sravani Avula and Seshadri, {Dhruv R.} and Akash Patel and Munes Fares and Orkun Baloglu and Shahnawaz Amdani and Roozbeh Jafari and Inan, {Omer T.} and Drummond, {Colin K.}",

note = "Publisher Copyright: {\textcopyright} 2023 The Authors",

year = "2023",

month = mar,

doi = "10.1016/j.jacadv.2023.100267",

language = "English (US)",

volume = "2",

journal = "JACC: Advances",

issn = "2772-963X",

number = "2",

}

TY - JOUR

T1 - Wearable Biosensors in Congenital Heart Disease

T2 - Needs to Advance the Field

AU - Tandon, Animesh

AU - Nguyen, Hoang H.

AU - Avula, Sravani

AU - Seshadri, Dhruv R.

AU - Patel, Akash

AU - Fares, Munes

AU - Baloglu, Orkun

AU - Amdani, Shahnawaz

AU - Jafari, Roozbeh

AU - Inan, Omer T.

AU - Drummond, Colin K.

PY - 2023/3

Y1 - 2023/3

N2 - Traditional measures of clinical status and physiology have generally been based in health care settings, episodic, short in duration, and performed at rest. Wearable biosensors provide an opportunity to obtain continuous non-invasive physiologic data from patients with congenital heart disease (CHD) in the real-world setting, over longer durations, and across varying levels of activity. However, there are significant technical limitations to the use of wearable biosensors in CHD. Here, we review current applications of wearable biosensors in CHD; how clinical and research uses of wearable biosensors must consider various CHD physiologies; the technical challenges in developing wearable biosensors for CHD; and special considerations for digital biomarkers in CHD.

AB - Traditional measures of clinical status and physiology have generally been based in health care settings, episodic, short in duration, and performed at rest. Wearable biosensors provide an opportunity to obtain continuous non-invasive physiologic data from patients with congenital heart disease (CHD) in the real-world setting, over longer durations, and across varying levels of activity. However, there are significant technical limitations to the use of wearable biosensors in CHD. Here, we review current applications of wearable biosensors in CHD; how clinical and research uses of wearable biosensors must consider various CHD physiologies; the technical challenges in developing wearable biosensors for CHD; and special considerations for digital biomarkers in CHD.

KW - artificial intelligence

KW - congenital heart disease

KW - wearable biosensors

KW - wearables

UR - http://www.scopus.com/inward/record.url?scp=85163417209&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85163417209&partnerID=8YFLogxK

U2 - 10.1016/j.jacadv.2023.100267

DO - 10.1016/j.jacadv.2023.100267

M3 - Review article

C2 - 37152621

AN - SCOPUS:85163417209

SN - 2772-963X

VL - 2

JO - JACC: Advances

JF - JACC: Advances

IS - 2

M1 - 100267

ER -

Wearable Biosensors in Congenital Heart Disease: Needs to Advance the Field

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this